Premium
RIO Kinase 3 is a Novel, Orally Targetable Repressor of Fetal Hemoglobin
Author(s) -
Bjorg Gudmundsdottir,
Laxminath Tumburu,
John F. Tisdale
Publication year - 2020
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2020.34.s1.08713
Subject(s) - fetal hemoglobin , repressor , kinase , fetus , hemoglobin , medicine , microbiology and biotechnology , pharmacology , biology , genetics , pregnancy , gene , transcription factor
Withdrawal: Gudmundsdottir, B., Tumburu, L. and Tisdale, J.F. (2020), RIO Kinase 3 is a Novel, Orally Targetable Repressor of Fetal Hemoglobin. The FASEB Journal, 34: 1‐1. doi: 10.1096/fasebj.2020.34.s1.08713 . The above abstract, published online on April 19, 2020 in Wiley Online Library (wileyonlinelibrary.com), has been withdrawn by agreement between the authors, FASEB, and Wiley Periodicals Inc. The withdrawal is due to a request made by the authors prior to publication. The Publisher apologizes that this abstract was published in error.